A COMMENTARY ON THE USE OF HEPATOCYTES IN DRUG METABOLISM STUDIES DURING DRUG DISCOVERY AND DEVELOPMENT*

REFERENCES

• Parkinson A. Biotransformation of xenobiotics. Casarette and Doull's Toxicology, The Basic Science of Poisons, C. D. Klassen. 5th ed., McGraw-Hill, New York 1996; 113–186
   Google Scholar
• Denk H. Human surgical and postmortem material. Ethically justifiable?. Scientific Alternatives to Animal Experiments, F. Lembeck. Ellis Horwood, Chichester 1989; 75–79
   Google Scholar
• Bayliss M. K., Skett P. Isolation and culture of human hepatocytes. Human Cell Culture Protocols, G. E. Jones. Humana Press, Totowa, , NJ 1996; 369–389
   Google Scholar
• Berry M. N., Edwards A. M., Barritt G. J. Laboratory Techniques in Biochemistry and Molecular Biology. Isolated Hepatocyte Preparation; Properties and Applications, R. H. Burdon, P. H. van Knippenberg. Elsevier, Amsterdam 1991; 21: 1–460
   Google Scholar
• Lavrijsen K., van Houdt J., van Dyck D., Hendrickx J., Bockx M., Hurkmans W., Meuldermans W., Jeune L. Le, Lauwers W., Heykants J. Comparative metabolism of flunarizine in rats, dogs and man: An in vitro study with subcellular liver fractions and isolated hepatocytes. Xenobiotica 1992; 22(7)815–836
   PubMed Web of Science ®Google Scholar
• Sandker G. W., Vos R. M. E., Delbressine P. C., Slooff M. J. H., Meijer D. K. F., Groothuis G. M. M. Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: Analysis of interspecies variability and comparison with metabolism in vivo. Xenobiotica 1994; 24(2)143–155
   PubMed Web of Science ®Google Scholar
• Rahmani R., Sousa G. de, Marre F., Nicolas F., Placidi M. Potential of freshly isolated and cryopreserved human hepatocytes in drug research and development. Human Cells in In Vitro Pharmaco-toxicology, V. Rogiers, W. Sonck, E. Shephard, A. Vercruysse. Vub Press, Brussels 1993; 117–138
   Google Scholar
• Pahernik S. A., Schmid J., Sauter T., Schildberg F. W., Koebe H. -G. Metabolism of pimobendan in long-term human hepatocyte culture: In vivo–in vitro comparison. Xenobiotica 1995; 25(8)811–823
   PubMed Web of Science ®Google Scholar
• Souza G. de, Florence N., Valleès B., Coassolo P., Rahmani R. Relationships between in vitro and in vivo biotransformation of drugs in humans and animals: Pharmaco-toxicological consequences. Cell Biol. Toxicol. 1995; 11: 147–153
   PubMed Web of Science ®Google Scholar
• Maurel P. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Adv. Drug Deliv. Rev. 1996; 22: 105–132
   Web of Science ®Google Scholar
• Bayliss M. K., Bell J. A., Jenner W. N., Park G. R., Wilson K. Utility of hepatocytes to model species differences in metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man. Xenobiotica 1999; 29(3)253–268
   PubMed Web of Science ®Google Scholar
• Humpel M., Sostarek D., Gieschen H., Labitzky C. Studies on the biotransformation of ionazolac, bromerguride, lisuride and terguride in laboratory animals and their hepatocytes. Xenobiotica 1989; 19: 361–377
   PubMed Web of Science ®Google Scholar
• Chenery R. J., Ayrton A., Oldham H. G., Standring P., Norman S. J., Seddon T., Kirby R. Diazepam metabolism in cultured hepatocytes from rat, rabbit, dog, guinea pig and man. Drug Metab. Dispos. 1987; 15: 312–317
   PubMed Web of Science ®Google Scholar
• Lave T., Dupin S., Schmitt M., Kapps M., Meyer J., Morgenroth B., Chou R. C., Jaeck D., Coassolo P. Interspecies scaling of tolcapone, a new inhibitor of catechol-O-methyltransferase. Use of in vitro data from hepatocytes to predict metabolic clearance in animals and humans. Xenobiotica 1996; 26: 839–851
   PubMed Web of Science ®Google Scholar
• Lave T., Coassolo P., Ubeaud G., Brandt B. B. R., Schmitt C., Dupin S., Jaeck D., Chou R. C. Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling. Pharmaceut. Res. 1996; 13: 97–101
   PubMed Web of Science ®Google Scholar
• Cross D. M. A consideration of the enzymology underlying ranitidine metabolism and drug interations. J. Biopharmaceut. Sci. 1991; 2(4)339–377
   Google Scholar
• Ammann P., Maier P. Preservation and inducibility of xenobiotic metabolism in long-term cultures of adult rat liver cell aggregates. Toxicol. In Vitro 1997; 11: 43–56
   PubMed Web of Science ®Google Scholar
• Diaz D., Fabre I., Daujat M., Saint-Aubert B., Borries P., Michel H., Maurel P. Omeprazole is an aryl hydrocarbon like inducer of human hepatic cytochrome P450. Gastroenterology 1990; 69: 737–747
   Google Scholar
• Kern A., Bader A., Pichmayr R., Sewing K. F. Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochem. Pharmacol. 1997; 54: 761–772
   PubMed Web of Science ®Google Scholar
• Ferrini J -B., Pichard L., Domergue J., Maurel P. Long-term primary cultures of adult human hepatocytes. Chem.-Biol. Interact. 1997; 107: 31–45
   PubMed Web of Science ®Google Scholar
• Pichard L., Fabre I., Fabre G., Domergue J., Aubert B. S., Mourad G., Maurel P. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P450 (Cyclosporin A Oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab. Dispos. 1990; 18(5)595–606
   PubMed Web of Science ®Google Scholar
• Skett P. Problems in using isolated and cultured hepatocytes for xenobiotic metabolism / metabolism-based toxicity testing—solutions. Toxicol. In Vitro 1994; 8(3)491–504
   PubMed Web of Science ®Google Scholar
• Guillouzo A., Morel F., Ratanasavanh D., Chesne C., Guguen-Guillouzo C. Long-term cultures of functional hepatocytes. Toxicol. In Vitro 1990; 4(5 / 4)415–427
   PubMed Web of Science ®Google Scholar
• Koebe H -G, Pahernik S., Eyer P., Schildberg F -W. Collagen gel immobilisation: A useful cell culture technique for long-term metabolic studies on human hepatocytes. Xenobiotica 1994; 24(2)95–107
   PubMed Web of Science ®Google Scholar
• Liu L., LeCluyse E. L., Liu J., Klaassen C. D. Sulfotransferase gene expression in primary cultures of rat hepatocytes. Biochem. Pharmacol. 1996; 52: 1621–1630
   PubMed Web of Science ®Google Scholar
• Guillouzo A., Begue J -M., Campion J -P., Gascoin M -N., Guguen-Guillouzo C. Human hepatocyte cultures: a model of pharmaco-toxicological studies. Xenobiotica 1985; 15(8 / 9)635–641
   PubMed Web of Science ®Google Scholar
• Guillouzo A., Begue J -M., Maurer G., Koch P. Identification of metabolic pathways of pindolol and fluperlapine in adult human hepatocyte cultures. Xenobiotica 1988; 18: 131–139
   PubMed Web of Science ®Google Scholar
• Donato M. T., Castell J. V., Goónnez-Lechoón M. J. Co-cultures of hepatocytes with epithelial-like cell lines: Expression of drug biotransformation activities by hepatocytes. Cell Biol. Toxicol. 1991; 7(1)1–14
   PubMed Web of Science ®Google Scholar
• Sidhu J. S., Farin F. M., Omiecinski C. J. Influence of extracellular matrix overlay on phenobarbital-mediated induction of CYP2B1, 2B2 and 3A1 genes in primary adult rat hepatocyte culture. Arch. Biochem. Biophys. 1993; 301(1)103–113
   PubMed Web of Science ®Google Scholar
• LeCluyse E. L., Audus K. L., Hochman J. H. Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am. J. Physiol. 1994; 266: C1764–C1774, Cell Physiol. 35
   PubMed Web of Science ®Google Scholar
• Oesch F., Diener B. Cell sys tems for use in studies on the relationship between foreign compound metabolism and toxicity. Pharmacol. Toxicol. 1995; 76: 325–327
   PubMedGoogle Scholar
• Rogiers V. Cultures of human hepatocytes in in vitro pharmaco-toxicology. Human Cells in In Vitro Pharmaco-toxicology, V. Rogiers, W. Sonck, E. Shephard, A. Vercruysse. Vub Press, Brussels 1993; 77–115
   Google Scholar
• Guillouzo A., Morel F., Fardel O., Meunier B. Use of human hepatocyte cultures for drug metabolism studies. Toxicology 1993; 82: 209–219
   PubMed Web of Science ®Google Scholar
• Rogiers V., Vercruysse A. Rat hepatocyte cultures and co-cultures in biotransformation studies of xenobiotics. Toxicology 1993; 82: 193–208
   PubMed Web of Science ®Google Scholar
• Kono Y., Yang S., Roberts E. Extended primary culture of human hepatocytes in a collagen gel sandwich system. In Vitro Cell Dev. Biol.-Animal 1997; 33: 467–472
   PubMed Web of Science ®Google Scholar
• Guyomard C., Rialland L., Fremond B., Chesne C., Guillouzo A. Influence of alginate gel entrapment and cryopreservation on survival and xenobiotic metabolism capacity of rat hepatocytes. Toxicol. Appl. Pharmacol. 1996; 141(2)349–356
   PubMed Web of Science ®Google Scholar
• Selden C., Roberts E., Stamp G., Parker K., Winlove P., Ryder T., Platt H., Hodgson H. Comparison of three solid phase supports for promoting three-dimensional growth and function of human liver cell lines. Artif. Organs 1998; 22(4)308–319
   PubMed Web of Science ®Google Scholar
• Roberts R. A., Soames A. R. Hepatocyte spheroids: Prolonged hepatocyte viability for in vitro modeling of nongenotoxic carcinogenesis. Fundam. Appl. Toxicol. 1993; 21: 149–158
   PubMedGoogle Scholar
• Tong J. Z., DeLagausie P., Furlan V., Cresteil T., Bernard O., Alvarez F. Long-term culture of adult rat hepato cyte spheroids. Exp. Cell Res. 1992; 200: 326–332
   PubMed Web of Science ®Google Scholar
• Abdel-Razzak Z., Loyer P., Fautrel A., Gautier J. C., Corcos L., Turlin B., Beaune P., Guillouzo A. Cytokines down-regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 1993; 44: 770–775
   Google Scholar
• Bader A., Zech K., Crome O., Christians U., Ringe B., Pichlmayr R., Sewing K. -F. R. Use of organotypical cultures of primary hepatocytes to analyse drug bio- transformation in man and animals. Xenobiotica 1994; 24(7)623–633
   PubMed Web of Science ®Google Scholar
• Rotem A., Matthew H. W. T., Hsiao P. H., Toner M., Tompkins R. G., Yarmush M. L. The activity of cytochrome P450IA1 in stable cultured rat hepatocytes. Toxicol. In Vitro 1995; 9(2)139–149
   PubMed Web of Science ®Google Scholar
• Bader A., Knop E., Kern A., Boöker K., Fruöhauf N., Crome O., Esselmann H., Pape C., Kempka G., Sewing K. -F. R. 3-D coculture of hepatic sinusoidal cells with primary hepatocytes—design of an organotypical model. Exp. Cell Res. 1996; 226: 223–233
   PubMed Web of Science ®Google Scholar
• Surapaneni S., Pryor T., Klein M., Matthew H. W. T. Rapid hepatocyte spheroid formation: Optimization and long term function in perfused microcapsules. ASAIO J. 1997; 43(5)848–853
   Google Scholar
• Takabatake H., Koide N., Tsuji T. Encapsulated multicellular spheroids of rat hepatocytes produce albumin and urea in a spouted bed circulating system. Artif. Organs. 1991; 15(6)474–480
   PubMed Web of Science ®Google Scholar
• Jauregui H. O., Naik S., Santangini H., Pan J., Trenkler D., Mullon C. Primary cultures of rat hepatocytes in hollow fiber chambers. In Vitro Cell Dev. Biol. 1994; 30A: 23–29
   Web of Science ®Google Scholar
• Rose M. L., Rusyn I., Bojes H. K., Germolec D. R., Luster M., Thurman R. G. Role of Kupffer cells in pe roxisome proliferator-induced hepatocyte proliferation. Drug Metab. Rev. 1999; 31(1)87–99
   PubMed Web of Science ®Google Scholar
• Worboys P. D., Bradbury A., Houston J. B. Kinetics of drug metabolism in rat liver slices, Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high- and low-clearance compounds. Drug Metab. Dispos. 1995; 23(3)393–397
   PubMed Web of Science ®Google Scholar
• Worboys P. D., Bradbury A., Houston J. B. Kinetics of drug metabolism in rat liver slices. II. Comparison of clearance by liver slices and freshly isolated hepatocytes. Drug Metab. Dispos. 1996; 24(6)676–681
   PubMed Web of Science ®Google Scholar
• Worboys P. D., Brennan B., Bradbury A., Houston J. B. Metabolite kinetics of ondansetron in rat. Comparison of hepatic microsomes, isolated hepatocytes and liver slices, with in vivo disposition. Xenobiotica 1996; 26(9)897–907
   PubMed Web of Science ®Google Scholar
• Worboys P. D., Bradbury A., Houston J. B. Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate. Drug Metab. Dispos. 1997; 25(4)460–467
   PubMed Web of Science ®Google Scholar
• Beamand J. A., Price R. J., Phillips J. C., Butler W. H., Jones G. D. Glynne, Osimitz T. G., Gabriel K. L., Preiss F. J., Lake B. G. Lack of effect of piperonyl butoxide on unscheduled DNA synthesis in precision-cut human liver slices. Mutat. Res. 1996; 371(3-4)273–282
   PubMed Web of Science ®Google Scholar
• Drahushuk A. T., McGarrigle B. P., Tai H. L., Kitareewan S., Goldstein J. A., Olson J. R. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxicol. Appl. Pharmacol. 1996; 140(2)393–403
   PubMed Web of Science ®Google Scholar
• Wright M. C., Paine A. J. Evidence that the loss of rat l iver cytochrome P450 in vitro is not solely associated with the use of collagenase, the loss of cell-cell contacts and mh50/ mh50or the absence of an extracellular matrix. Biochem. Pharmacol. 1992; 43(2)237–243
   PubMed Web of Science ®Google Scholar
• Powis G., Santone K. S., Melder D. C., Thomas L., Moore D. J., Wilke T. J. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation. Drug Metab. Dispos. 1987; 15(6)826–832
   PubMed Web of Science ®Google Scholar
• Loretz L. J., Li A. P., Flye M. W., Wilson A. G. E. Optimization of cryopreservation procedures for rat and human hepatocytes. Xenobiotica 1989; 19(5)489–498
   PubMed Web of Science ®Google Scholar
• Coundouris J. A., Grant M. H., Engeset J., Petrie J. C., Hawksworth G. M. Cryopreservation of human adult hepatocytes for use in drug metabolism and toxicity studies. Xenobiotica 1993; 23(12)1399–1409
   PubMed Web of Science ®Google Scholar
• Pang J. M., Zaleski J., Kauffman F. C. Toxicity of allyl alcohol in primary cultures of freshly isolated and cryopreserved hepatocytes maintained on hydrated collagen gels. Toxicol. Appl. Pharmacol. 1997; 142: 87–94
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Microsomal flavin-containing monooxygenase: oxygenation of nucleophilic nitrogen and sulfur compounds. Enzymatic Basis of Detoxication 1, W. B. Jakoby. Academic Press, New York 1980; 201–227
   Google Scholar
• Ziegler D. M. Flavin-containing monooxygenases: Catalytic mechanism and substrate specificities. Drug Metab. Rev. 1988; 19(1)1–32
   PubMed Web of Science ®Google Scholar
• Prough R. A., Ziegler D. M. The relative participation of liver microsomal amine oxidase and cytochrome P450 in N-demethylation reactions. Arch. Biochem. Biophys. 1977; 180: 363–373
   PubMed Web of Science ®Google Scholar
• Kedderis G. L., Rickert D. E. Inhibition of the microsomal N-hydroxylation of 2-amino-6-nitrotoluene by a metabolite of methimazole. Biochem. Biophys. Res. Commun. 1983; 113(2)433–438
   PubMed Web of Science ®Google Scholar
• Guo Z., Raeissi S., White R. B., Stevens J. C. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab. Dispos. 1997; 25(3)390–393
   PubMed Web of Science ®Google Scholar
• James S. P. The biochemistry of endogenous organosulphur compounds. Drug Metab. Drug Interact. 1988; 6(3–4)167–182
   PubMedGoogle Scholar
• Watkins J. B., Klaassen C. D. Chemically-induced alteration of UDP-glucuronic acid concentration in rat liver. Drug Metab. Dispos. 1983; 11: 37–40
   PubMed Web of Science ®Google Scholar
• Mizuma T., Machida M., Hayashi M., Awazu S. Correlation of drug conjugative metabolism rates between in vivo and in vitro : Glucuronidation and sulphation of p-nitrophenol as a model compound. J. Pharmacobiodyn 1982; 5: 811–817
   PubMedGoogle Scholar
• Schwarz L. R. Modulation of sulphation and glucuronidation of 1-naphthol in isolated rat liver cells. Arch. Toxicol. 1980; 44: 137–145
   PubMed Web of Science ®Google Scholar
• Oddy E., Manchee M., Coughtrie M. W. H. Assessment of rat liver slices as a suitable model system for studying the simultaneous sulphation and glucuronidation of phenolic xenobiotics. Xenobiotica 1997; 27(4)369–377
   PubMed Web of Science ®Google Scholar
• Singh K., Tripp S. L., Dunton A. W., Douglas F. L., Rakhit A. Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes. Drug Metab. Dispos. 1991; 19: 990–995
   PubMed Web of Science ®Google Scholar
• Ashforth E. L., Carlile D. J., Chenery R. J., Houston J. B. Prediction of in vivo disposition from in vitro systems: Clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data. J. Pharmacol. Exp. Therapeut. 1995; 274: 761–766
   PubMed Web of Science ®Google Scholar
• Hayes K. A., Brennan B., Chenery R. J., Houston J. B. In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data. Drug Metab. Dispos. 1995; 23: 349–353
   PubMed Web of Science ®Google Scholar
• Zomorodi K., Carlile D. J., Houston J. B. Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance. Xenobiotica 1995; 25: 907–916
   PubMed Web of Science ®Google Scholar
• Lave T., Schmitt-Hoffman A. H., Coassolo P., Valles B., Ubeaud G., Brandt B. B. R., Chou R. C. A new extrapolation method from animals to man: Application to a metabolised compound, mofarotene. Life Sci. 1995; 56: 473–478
   Web of Science ®Google Scholar
• Carlile D. J., Zomorodi K., Houston J. B. Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes and intact liver. Drug Metab. Dispos. 1997; 25: 903–911
   PubMed Web of Science ®Google Scholar
• Lave T., Dupin S., Schmitt C., Valles B., Ubeaud G., Chou R., Jaeck D., Coassolo P. The use of hepatocytes to select compounds based on their expected extraction ratios in humans. Pharmaceut. Res. 1997; 14: 152–155
   PubMed Web of Science ®Google Scholar
• Iwatsubo T., Hirota N., Ooie T., Suzuki H., Shimada N., Chiba K., Ishizaki T., Green C. E., Tyson C. A., Sugiyama Y. Prediction of in vivo metabolism in the human liver from in vitro metabolism data. Pharmacol. Therapeut. 1997; 73: 147–171
   PubMed Web of Science ®Google Scholar
• Boxenbaum H., Lea C. di. First-time in human dose selection: Allometric thoughts and perspectives. J. Clin. Pharmacol. 1995; 35: 957–966
   PubMed Web of Science ®Google Scholar
• Ubeaud G., Schmitt C., Jaeck D., Lave T., Coassolo Ph. Bosentan, a new endothelin receptor antagonist: Prediction of the systemic plasma clearance in man from combined in vivo and in vitro data. Xenobiotica 1995; 25(12)1381–1390
   PubMed Web of Science ®Google Scholar
• Houston J. B., Carlile D. J. Incorporation of in vitro drug metabolism data into physiologically based pharmacokinetic models. Toxicol. In Vitro 1997; 11: 473–478
   PubMed Web of Science ®Google Scholar
• Houston J. B. Relevance of in vitro kinetic parameters to in vivo metabolism of xenobiotics. Toxicol. In Vitro 1994; 8(4)507–512
   PubMed Web of Science ®Google Scholar
• Houston J. B. Commentary. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 1994; 47: 1469–1479
   PubMed Web of Science ®Google Scholar
• Vickers A. E. M., Connors S., Zollinger M., Biggi W. A., Larrauri A., Vogelaar J. P. W., Brendel K. The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance. Drug Metabol. Dispos. 1993; 21(3)454–459
   PubMed Web of Science ®Google Scholar
• Oldham H. G., Chenery R. J., Standring P., Norman S. J., Garton A., Ayrton A. D. Drug metabolism kinetic studies in a hepatocyte model. Food Chem. Toxicol. 1986; 24: 761–762
   Web of Science ®Google Scholar
• Pang K. S., Kong P., Terrell J. A., Billings R. E. Metabo lism of acetaminophen and phenacetin by isolated rat hepatocytes. Drug Metabol. Dispos. 1985; 13: 42–50
   PubMed Web of Science ®Google Scholar
• Bodd E., Drevon C. A., Kveseth N., Olsen H., Morland J. Ethanol inhibition of codeine and morphine metabolism in isolated rat hepatocytes. J. Exp. Therapeut. 1986; 237: 260–264
   PubMed Web of Science ®Google Scholar
• Arias I. M. Introduction. The Liver: Biology and Pathobiology, I. M. Arias, W. B. Jakoby, H. Popper, D. Scahacter, D. A. Shafritz. Raven Press, New York 1988; 3–10
   Google Scholar
• Morgan D. J., Smallwood R. A. Clinical significance of pharmacokinetics: Models of hepatic elimination. Clin. Pharmacokinet. 1990; 18: 61–76
   PubMed Web of Science ®Google Scholar
• Ekins S., Williams J. A., Murray G. I., Burke M. D., Marchant N. C., Engeset J., Hawkesworth G. M. Xenobiotic metabolism in rat, dog and human precision-cut liver slices, freshly isolated hepatocytes and vitrified precision-cut liver slices. Drug Metab. Dispos. 1996; 24: 990–995
   PubMed Web of Science ®Google Scholar
• Ito K., Iwatsubo T., Kanamitsu S., Nakajima N., Sugiyama Y. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Ann. Rev. Pharmacol. Toxicol. 1998; 38: 461–499
   PubMed Web of Science ®Google Scholar
• Mahmood I., Balian J. D. The pharmacokinetics principles behind scaling from preclinical results to Phase 1 protocols. Clin. Pharmacokinet. 1999; 36(1)1–11
   PubMed Web of Science ®Google Scholar
• Boxenbaum H. Interspecies variation in liver weight, hepatic blood flow and antipyrene clearance: Extrapolation of data to benzodiazepines and phenytoin. J. Pharmacokinet. Biopharmaceut. 1980; 8: 165–176
   PubMedGoogle Scholar
• Varughese A., Lee C -S. C. Disposition kinetics of ranitidine in rats. Drugs Exp. Clin. Res. 1983; 9(11)837–842
   Google Scholar
• Eddershaw P. J., Chadwick A. P., Higton D. M., Fenwick S. H., Linacre P., Jenner W. N., Bell J. A., Manchee G. R. Absorption and disposition of ranitidine hydrochloride in rat and dog. Xenobiotica 1996; 26(9)947–956
   PubMed Web of Science ®Google Scholar
• Mitchard M., McIsaac R. L., Bell J. A. H2-receptor antagonists. Sulphur-Containing Drugs and Related Organic Compounds, L. A. Damani. Part A, Ellis Horwood, Chichester 1989; 3: 53–86
   Google Scholar